393 related articles for article (PubMed ID: 29505935)
1. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.
Dadashpour S; Emami S
Eur J Med Chem; 2018 Apr; 150():9-29. PubMed ID: 29505935
[TBL] [Abstract][Full Text] [Related]
2. Indole: A privileged scaffold for the design of anti-cancer agents.
Wan Y; Li Y; Yan C; Yan M; Tang Z
Eur J Med Chem; 2019 Dec; 183():111691. PubMed ID: 31536895
[TBL] [Abstract][Full Text] [Related]
3. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
Patil R; Patil SA; Beaman KD; Patil SA
Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
[TBL] [Abstract][Full Text] [Related]
4. Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.
Singh AK; Raj V; Saha S
Eur J Med Chem; 2017 Dec; 142():244-265. PubMed ID: 28803677
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.
Youssif BGM; Abdelrahman MH; Abdelazeem AH; Abdelgawad MA; Ibrahim HM; Salem OIA; Mohamed MFA; Treambleau L; Bukhari SNA
Eur J Med Chem; 2018 Feb; 146():260-273. PubMed ID: 29407956
[TBL] [Abstract][Full Text] [Related]
6. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.
Patil SA; Patil R; Miller DD
Future Med Chem; 2012 Oct; 4(16):2085-115. PubMed ID: 23157240
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.
Fortes MP; da Silva PB; da Silva TG; Kaufman TS; Militão GC; Silveira CC
Eur J Med Chem; 2016 Aug; 118():21-6. PubMed ID: 27116711
[TBL] [Abstract][Full Text] [Related]
8. Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review.
Rathi AK; Syed R; Singh V; Shin HS; Patel RV
Recent Pat Anticancer Drug Discov; 2017; 12(1):55-72. PubMed ID: 27697069
[TBL] [Abstract][Full Text] [Related]
9. How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors.
Mondal D; Amin SA; Moinul M; Das K; Jha T; Gayen S
Bioorg Med Chem; 2022 Jan; 53():116534. PubMed ID: 34864496
[TBL] [Abstract][Full Text] [Related]
10. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
11. Cyclohepta[b]indoles: A Privileged Structure Motif in Natural Products and Drug Design.
Stempel E; Gaich T
Acc Chem Res; 2016 Nov; 49(11):2390-2402. PubMed ID: 27709885
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
Singh P; Kaur M; Verma P
Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.
Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA
Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811
[TBL] [Abstract][Full Text] [Related]
16. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.
Sidhu JS; Singla R; Mayank ; Jaitak V
Anticancer Agents Med Chem; 2015; 16(2):160-73. PubMed ID: 25991424
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Azerang P; Sardari S; Kobarfard F
Arch Pharm Res; 2021 Aug; 44(8):1-13. PubMed ID: 24062081
[TBL] [Abstract][Full Text] [Related]
18. The importance of indole and azaindole scaffold in the development of antitumor agents.
Han Y; Dong W; Guo Q; Li X; Huang L
Eur J Med Chem; 2020 Oct; 203():112506. PubMed ID: 32688198
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Buyanov VN; Treshalina HM; Lesnaya NA; Romanenko VI; Kaluzhny DN; Balzarini J; Agama K; Pommier Y; Shtil AA; Preobrazhenskaya MN
Eur J Med Chem; 2014 Oct; 86():797-805. PubMed ID: 25244612
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX
Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
